Version 1
: Received: 31 October 2024 / Approved: 2 November 2024 / Online: 4 November 2024 (10:44:15 CET)
How to cite:
Moreno-Juste, A.; Poblador-Plou, B.; Laguna-Berna, C.; Cruces-Mateo, B.; Lenotti, E.; Santos-Mejías, A.; Gimeno-Feliu, L. A.; Gimeno-Miguel, A. Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain. Preprints2024, 2024110120. https://doi.org/10.20944/preprints202411.0120.v1
Moreno-Juste, A.; Poblador-Plou, B.; Laguna-Berna, C.; Cruces-Mateo, B.; Lenotti, E.; Santos-Mejías, A.; Gimeno-Feliu, L. A.; Gimeno-Miguel, A. Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain. Preprints 2024, 2024110120. https://doi.org/10.20944/preprints202411.0120.v1
Moreno-Juste, A.; Poblador-Plou, B.; Laguna-Berna, C.; Cruces-Mateo, B.; Lenotti, E.; Santos-Mejías, A.; Gimeno-Feliu, L. A.; Gimeno-Miguel, A. Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain. Preprints2024, 2024110120. https://doi.org/10.20944/preprints202411.0120.v1
APA Style
Moreno-Juste, A., Poblador-Plou, B., Laguna-Berna, C., Cruces-Mateo, B., Lenotti, E., Santos-Mejías, A., Gimeno-Feliu, L. A., & Gimeno-Miguel, A. (2024). Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain. Preprints. https://doi.org/10.20944/preprints202411.0120.v1
Chicago/Turabian Style
Moreno-Juste, A., Luis Andrés Gimeno-Feliu and Antonio Gimeno-Miguel. 2024 "Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain" Preprints. https://doi.org/10.20944/preprints202411.0120.v1
Abstract
Background/Objectives: Chronic liver disease (CLD) is highly relevant in clinical practice due to its increasing incidence and associated mortality. We aimed to exhaustively characterize the multimorbidity in patients with CLD. Methods: Retrospective observational study of patients aged 18 years and older with a diagnosis of CLD in 2015 in the EpiChron Cohort (Spain). We analysed the prevalence of comorbidities according to sex and age, conducted a logistic regression analysis with CLD as the independent variable and each of the comorbidities as dependent variables to obtain odds ratios (OR) adjusted for age and sex, and performed an exploratory factor analysis to identify the presence of multimorbidity patterns. Results: 6836 adults had a diagnosis of CLD (mean age 61.6 years; 62.5% women), with an average of 13 co-existing chronic conditions. Arterial hypertension, lipid metabolism disorders, diabetes, obesity, and musculoskeletal diseases were the most frequent diseases. From the list of 110 chronic conditions analysed, 75 were systematically associated with CLD, including (OR, 95% confidence interval) chronic pancreatitis (41.2, 33.5-50.6), and inherited metabolic disorders (14.9, 11.8-18.8). Three multimorbidity patterns were identified in both men and women, and called cardiovascular, metabolic-geriatric, and mental-substance use, with some differences by sex. Conclusions: Multimorbidity is the norm in patients with CLD. Our results reveal that a comprehensive and integral approach based on person-centred care, which should take into account their entire spectrum of multimorbidity, is necessary during the care of this type of patients in clinical practice.
Keywords
chronic liver disease; multimorbidity; comorbidity; population-based study
Subject
Medicine and Pharmacology, Internal Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
